Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 4;62(5):ezac409.
doi: 10.1093/ejcts/ezac409.

Unilateral left-sided thoracoscopic ablation of atrial fibrillation concomitant to minimally invasive bypass grafting of the left anterior descending artery

Affiliations

Unilateral left-sided thoracoscopic ablation of atrial fibrillation concomitant to minimally invasive bypass grafting of the left anterior descending artery

Claudia A J van der Heijden et al. Eur J Cardiothorac Surg. .

Abstract

Objectives: Thoracoscopic ablation for atrial fibrillation (AF) and minimally invasive direct coronary artery bypass (MIDCAB) with robot-assisted left internal mammary artery (LIMA) harvesting may represent a safe and effective alternative to more invasive surgical approaches via sternotomy. The aim of our study was to describe the feasibility, safety and efficacy of a unilateral left-sided thoracoscopic AF ablation and concomitant MIDCAB surgery.

Methods: Retrospective analysis of a prospectively gathered cohort was performed of all consecutive patients with AF and at least a critical left anterior descending artery (LAD) stenosis that underwent unilateral left-sided thoracoscopic AF ablation and concomitant off-pump MIDCAB surgery in the Maastricht University Medical Centre between 2017 and 2021.

Results: Twenty-three patients were included [age 69 years (standard deviation = 8), paroxysmal AF 61%, left atrial volume index 42 ml/m2 (standard deviation = 11)]. Unilateral left-sided thoracoscopic isolation of the left (n = 23) and right (n = 22) pulmonary veins and box (n = 21) by radiofrequency ablation was succeeded by epicardial validation of exit- and entrance block (n = 22). All patients received robot-assisted LIMA harvesting and off-pump LIMA-LAD anastomosis through a left mini-thoracotomy. The perioperative complications consisted of one bleeding of the thoracotomy wound and one aborted myocardial infarction not requiring intervention. The mean duration of hospital stay was 6 days (standard deviation = 2). After discharge, cardiac hospital readmission occurred in 4 patients (AF n = 1; pleural- and pericardial effusion n = 2, myocardial infarction requiring the percutaneous intervention of the LIMA-LAD n = 1) within 1 year. After 12 months, 17/21 (81%) patients were in sinus rhythm when allowing anti-arrhythmic drugs. Finally, the left atrial ejection fraction improved postoperatively [26% (standard deviation = 11) to 38% (standard deviation = 7), P = 0.01].

Conclusions: In this initial feasibility and early safety study, unilateral left-sided thoracoscopic AF ablation and concomitant MIDCAB for LIMA-LAD grafting is a feasible, safe and efficacious for patients with AF and a critical LAD stenosis.

Keywords: Atrial fibrillation; Minimally invasive; Minimally invasive direct coronary bypass grafting; Thoracoscopic ablation.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Flowchart representing patient individualized treatment strategies and outcomes. AF: atrial fibrillation; AFL: atrial flutter; AT: atrial tachycardia; CA: catheter ablation; CAD: coronary artery disease; CRT-D: cardiac resynchronization therapy-defibrillator; CTI: cavo-triscupid isthmus; ECV: electrical cardioversion; iCMP: ischaemic cardiomyopathy; LIMA-LAD: left internal mammary artery–left anterior descending artery; LV: left ventricle; NSTEMI: non-ST elevated myocardial infarction; PCI: percutaneous coronary intervention; PV: pulmonary vein; PVI: PV isolation; RCA: right coronary artery; RSPV: right superior pulmonary vein; SR: sinus rhythm; WACA: wide antral circumferential ablation.
Figure 2:
Figure 2:
Kaplan–Meier survival curve representing the probability of being free from atrial fibrillation recurrences. AF: atrial fibrillation.
Figure 3:
Figure 3:
Left atrial ejection fraction at baseline and after surgery.
None

Comment in

References

    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C. et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373–498. - PubMed
    1. Lapierre H, Chan V, Sohmer B, Mesana TG, Ruel M.. Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study. Eur J Cardiothorac Surg 2011;40:804–10. - PubMed
    1. Vos LM, Kotecha D, Geuzebroek GS, Hofman FN, Van Boven WJP, Kelder J. et al. Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis. Europace 2018;20:1790–7. - PMC - PubMed
    1. Maesen B, La Meir M.. Unilateral left-sided thoracoscopic ablation of atrial fibrillation. Ann Thorac Surg 2020;110:e63–6. - PubMed
    1. Nederlandse Hart Registratie. NHR Handbook. Nederlandse Hart Registratie, 2021.

Substances